Carregant...
Simplified steps to heterologous prime-boost HIV vaccine development?
The RV 144 HIV vaccine efficacy study showed a reduction in HIV-1 infection risk in Thai volunteers who received two priming vaccinations of vCP1521 ALVAC (attenuated recombinant canarypox virus expressing HIV group–specific antigen, polymerase, and envelope genes) followed by two additional ALVAC v...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6819123/ https://ncbi.nlm.nih.gov/pubmed/31566582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI132440 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|